| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/29/2004 | EP1461436A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 09/29/2004 | EP1461434A2 Compositions, methods and systems for discovery of lipopeptides |
| 09/29/2004 | EP1461433A1 Bacterial superantigen vaccines |
| 09/29/2004 | EP1461432A2 Nucleic acids related to plant retroelements |
| 09/29/2004 | EP1461430A2 Ovomucoid promoter and methods of use |
| 09/29/2004 | EP1461429A2 Means for identifying i neisseiria meningitidis /i -specific genes |
| 09/29/2004 | EP1461424A2 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 09/29/2004 | EP1461416A2 Enhanced proteins and methods for their use |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461353A2 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461087A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| 09/29/2004 | EP1461086A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 09/29/2004 | EP1461080A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461078A2 A PEPTIDE-BASED FLUORESCENCE POLARIZATION ASSAY FOR DETECTION OF ANTIBODIES TO i MYCOBACTERIUM BOVIS /i |
| 09/29/2004 | EP1461077A2 Polyvalent immunogen |
| 09/29/2004 | EP1461075A1 A rapid serological test for paratuberculosis using fluorescence polarization technology |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461071A1 Muscle transcription factors |
| 09/29/2004 | EP1461069A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 09/29/2004 | EP1461067A1 Compositions and method for treating hepatitis virus infection |
| 09/29/2004 | EP1461064A2 Bovine leptin protein, antisense and antibody |
| 09/29/2004 | EP1461001A2 Cancer-associated epitope |
| 09/29/2004 | EP1460900A2 Human secreted proteins |
| 09/29/2004 | EP1425575A4 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 09/29/2004 | EP1419171A4 Methods for purification of an activated peg solution and for the synthesis of a modified hemoglobin solution |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1322750A4 Proteolysis targeting chimeric pharmaceutical |
| 09/29/2004 | EP1276493B1 Cxcr4 agonist treatment of hematopoietic cells |
| 09/29/2004 | EP1265982B1 Method for the extraction of proteins from a single cell |
| 09/29/2004 | EP1191836B1 Polypeptide compositions formed using a coiled-coil template and methods of use |
| 09/29/2004 | EP1147130A4 Alpha-conotoxin peptides |
| 09/29/2004 | EP1140980B1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same |
| 09/29/2004 | EP1098907B1 Clarification of protein precipitate suspensions using anionic polymeric flocculants |
| 09/29/2004 | EP1090116B1 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof |
| 09/29/2004 | EP1060185A4 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/29/2004 | EP1023078A4 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 09/29/2004 | EP1015012A4 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0983300B1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
| 09/29/2004 | EP0980426B1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 09/29/2004 | EP0970119A4 Synaptic activation protein compositions and method |
| 09/29/2004 | EP0938572B1 Promoter from tobacco |
| 09/29/2004 | EP0914146B1 Morphogen treatment for chronic renal failure |
| 09/29/2004 | EP0804158B1 Compositions and methods for eliciting ctl immunity |
| 09/29/2004 | EP0742831B1 Transgenic non-human mammals with progressive neurologic disease |
| 09/29/2004 | EP0699079B1 Bioactive and/or targeted dendrimer conjugates comprising genetic materials |
| 09/29/2004 | EP0675903B1 Bone resorption assay |
| 09/29/2004 | EP0627925B1 Trypsin inhibitors |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533285A Adjuvant combination formulations |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533283A Use of osteopontin for treatment and/or prevention of neurologic diseases |
| 09/29/2004 | CN1532854A Composition and its preparing method |
| 09/29/2004 | CN1532289A Method for preparing N-end acetylation modified thymosin alpha with recombined E. coli |
| 09/29/2004 | CN1532284A Novel antibiotic polypeptide and its preparing method |
| 09/29/2004 | CN1532283A Novel anti-streptocouus pheumoniae polypeptide and its preparing method |
| 09/29/2004 | CN1532282A Novel antienterococci polypeptide and its preparing method |
| 09/29/2004 | CN1532207A Polyethylene glycol derivatives of thymosin alphal |
| 09/29/2004 | CN1532206A Active fragment of thymosin alphal and its polyethylene glycol derivatives |
| 09/29/2004 | CN1168828C Carotenoid production by fermentation |
| 09/29/2004 | CN1168825C Transcription factor from prunella asiatica, gene coding said factor and method for cultivating plant with adverse resistance |
| 09/29/2004 | CN1168739C Narcissus seed glycopeptide and its application |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/29/2004 | CN1168502C Porcine circovirus and parvovirus vaccine |
| 09/29/2004 | CN1168500C Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/29/2004 | CN1168495C Modified tumor necrosis factor |
| 09/28/2004 | US6797860 Promoter derived from phytosulfokine precursor gene |
| 09/28/2004 | US6797813 AK155 antibodies and binding fragments thereof |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797809 Multiple fusion antigens for use in immunoassays for anti-HCV antibodies |
| 09/28/2004 | US6797808 α-conotoxin peptides |
| 09/28/2004 | US6797807 Compounds and methods for cancer therapy |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797703 Gene therapy using TGF-β |
| 09/28/2004 | US6797702 Methods and compositions comprising DNA damaging agents and P53 |
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797695 Human FGF-20 gene and gene expression products |
| 09/28/2004 | US6797691 With pigment epithelium-derived factor (pedf) |
| 09/28/2004 | US6797690 Anti-freeze polypeptides for improving the freezing tolerance of foodstuffs |
| 09/28/2004 | US6797513 Nucleic acid encoding CLK2 protein kinases |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797506 Useful as animal vaccine (birds and humans) and for gene therapy; comprises heat shock proteins |
| 09/28/2004 | US6797505 Adeno-associated expression vector coding polypeptide for use in the treatment of blood disorders |
| 09/28/2004 | US6797501 Protein tyrosine phosphatase PTP20 and related products and methods |
| 09/28/2004 | US6797498 B, B-carotene 15, 15′-dioxygenases, nucleic acid sequences coding therefor and their use |
| 09/28/2004 | US6797495 Somatic cells with ablated PrP gene and methods of use |
| 09/28/2004 | US6797494 Containing locus control regions (lcr) from epstein-barr virus; globulins; genetic engineering |
| 09/28/2004 | US6797493 Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities |
| 09/28/2004 | US6797490 Nucleotide sequences coding polypeptide for use in biological pest control |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797488 Comprises yeast expression system producing biologically active fusion proteins at high titer; for cancer therapy |
| 09/28/2004 | US6797487 Polynucleotides encoding alzheimer's disease secretase |
| 09/28/2004 | US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/28/2004 | US6797485 Detecting bacterial propagation polypeptide; obtain bacteria, suspend in isotonic solution, centrifuge, incubae with ammonium sulfate, centrifuge, dissolve pellet, dry pellet, solubilize, expose to spectrum analysis |